145 related articles for article (PubMed ID: 28830494)
41. Kolaviron modulates angiogenesis, apoptosis and inflammatory signaling in rat model of testosterone propionate-induced benign prostate hyperplasia.
Farombi EO; Ajayi BO; Opata EK; Fafioye AO; Akinade AT
Inflammopharmacology; 2023 Aug; 31(4):2121-2131. PubMed ID: 36881348
[TBL] [Abstract][Full Text] [Related]
42. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia.
Shin IS; Lee MY; Jung DY; Seo CS; Ha HK; Shin HK
Food Chem Toxicol; 2012 Mar; 50(3-4):884-8. PubMed ID: 22266360
[TBL] [Abstract][Full Text] [Related]
43. Androgens and estrogens in benign prostatic hyperplasia: past, present and future.
Nicholson TM; Ricke WA
Differentiation; 2011; 82(4-5):184-99. PubMed ID: 21620560
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the effects of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression.
Cohen SM; Werrmann JG; Rasmusson GH; Tanaka WK; Malatesta PF; Prahalada S; Jacobs JG; Harris G; Nett TM
Prostate; 1995 Feb; 26(2):55-71. PubMed ID: 7531846
[TBL] [Abstract][Full Text] [Related]
45. Chemical profiles of the active fraction from Prinsepia utilis Royle leaves and its anti-benign prostatic hyperplasia evaluation in animal models.
Peng Y; Peng C; Wu Y; Sun C; Li X
BMC Complement Med Ther; 2021 Oct; 21(1):272. PubMed ID: 34715848
[TBL] [Abstract][Full Text] [Related]
46. Anti-proliferation effects of Cistanches salsa on the progression of benign prostatic hyperplasia.
Jeon HJ; Chung KS; An HJ
Can J Physiol Pharmacol; 2016 Jan; 94(1):104-11. PubMed ID: 27123496
[TBL] [Abstract][Full Text] [Related]
47. Heat-Killed and Live
Choi YJ; Fan M; Tang Y; Iwasa M; Han KI; Lee H; Hwang JY; Lee B; Kim EK
J Microbiol Biotechnol; 2021 Aug; 31(8):1134-1143. PubMed ID: 34226410
[TBL] [Abstract][Full Text] [Related]
48. Naftopidil enantiomers suppress androgen accumulation and induce cell apoptosis via the UDP-glucuronosyltransferase 2B15 in benign prostate hyperplasia.
Zhan H; Zhang S; Li L; Chen Z; Cai Y; Huang J; Wu D; Huang B; Wu B; Liu X
J Steroid Biochem Mol Biol; 2022 Jul; 221():106117. PubMed ID: 35504423
[TBL] [Abstract][Full Text] [Related]
49. Rauwolfia vomitoria extract suppresses benign prostatic hyperplasia by reducing expression of androgen receptor and 5α-reductase in a rat model.
Fang T; Xue ZS; Li JX; Liu JK; Wu D; Li MQ; Song YT; Yun SF; Yan J
J Integr Med; 2021 May; 19(3):258-264. PubMed ID: 33341427
[TBL] [Abstract][Full Text] [Related]
50. Subchronic toxicity of Acorus gramineus rhizoma in rats.
Lee YH; Kim D; Lee MJ; Kim MJ; Jang HS; Park SH; Lee JM; Lee HY; Park CB; Han BS; Son WC; Kang JS; Kang JK
J Ethnopharmacol; 2016 May; 183():46-53. PubMed ID: 26924566
[TBL] [Abstract][Full Text] [Related]
51. [Efficacy of Kangshuailing Gao on benign prostatic hyperplasia in rats].
Li R; Jia DY; Li Z; Xu DR; Luo SY
Zhonghua Nan Ke Xue; 2018 Aug; 24(8):729-734. PubMed ID: 30173434
[TBL] [Abstract][Full Text] [Related]
52. Serenoa repens extracts: In vitro study of the 5α-reductase activity in a co-culture model for Benign Prostatic Hyperplasia.
Buonocore D; Verri M; Cattaneo L; Arnica S; Ghitti M; Dossena M
Arch Ital Urol Androl; 2018 Sep; 90(3):199-202. PubMed ID: 30362688
[TBL] [Abstract][Full Text] [Related]
53. Umbelliferone Ameliorates Benign Prostatic Hyperplasia by Inhibiting Cell Proliferation and G1/S Phase Cell Cycle Progression through Regulation of STAT3/E2F1 Axis.
Kim HJ; Jin BR; An HJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445725
[TBL] [Abstract][Full Text] [Related]
54. Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens.
Marks LS; Hess DL; Dorey FJ; Luz Macairan M; Cruz Santos PB; Tyler VE
Urology; 2001 May; 57(5):999-1005. PubMed ID: 11337315
[TBL] [Abstract][Full Text] [Related]
55. Purple Corn Extract Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
Kim HJ; Kim BH; Jin BR; Park SJ; An HJ
J Agric Food Chem; 2022 May; 70(18):5561-5569. PubMed ID: 35466676
[TBL] [Abstract][Full Text] [Related]
56. Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase.
Choi HM; Jung Y; Park J; Kim HL; Youn DH; Kang J; Jeong MY; Lee JH; Yang WM; Lee SG; Ahn KS; Um JY
Sci Rep; 2016 Aug; 6():31906. PubMed ID: 27549514
[TBL] [Abstract][Full Text] [Related]
57. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
[TBL] [Abstract][Full Text] [Related]
58. SH-PRO extract alleviates benign prostatic hyperplasia via ROS-mediated activation of PARP/caspase 3 and inhibition of FOXO3a/AR/PSA signaling in vitro and in vivo.
Park JE; Shin WC; Lee HJ; Yoon D; Sim DY; Ahn CH; Park SY; Shim BS; Park SJ; Kim KS; Park GD; Kim SH; Lee DY
Phytother Res; 2023 Feb; 37(2):452-463. PubMed ID: 36122906
[TBL] [Abstract][Full Text] [Related]
59. Inhibitory effects of Tripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats.
Shen HN; Xu Y; Jiang ZZ; Huang X; Zhang LY; Wang T
Chin J Nat Med; 2015 Jun; 13(6):421-7. PubMed ID: 26073338
[TBL] [Abstract][Full Text] [Related]
60. Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.
Jin BR; Kim HJ; Na JH; Lee WK; An HJ
J Adv Res; 2024 Mar; 57():135-147. PubMed ID: 37061215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
